Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Seventy detoxified heroin-addicted patients were randomly assigned to one of two groups receiving ketamine psychotherapy (KPT) involving two different doses of ketamine. The patients of the experimental group received existentially oriented psychotherapy in combination with a hallucinogenic ("psychedelic") dose of ketamine (2.0 mg/kg im). The patients of the control group received the same psychotherapy combined with a low, non-hallucinogenic (non-psychedelic), dose of ketamine (0.2 mg/kg im). Both the psychotherapist and patient were blind to the dose of ketamine. The therapy included preparation for the ketamine session, the ketamine session itself, and the post session psychotherapy aimed to help patients to integrate insights from their ketamine session into everyday life. The results of this double blind randomized clinical trial of KPT for heroin addiction showed that high dose (2.0 mg/kg) KPT elicits a full psychedelic experience in heroin addicts as assessed quantitatively by the Hallucinogen Rating Scale. On the other hand, low dose KPT (0.2 mg/kg) elicits "sub-psychedelic" experiences and functions as ketamine-facilitated guided imagery. High dose KPT produced a significantly greater rate of abstinence in heroin addicts within the first two years of follow-up, a greater and longer-lasting reduction in craving for heroin, as well as greater positive change in nonverbal unconscious emotional attitudes than did low dose KPT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they also appear to have broad therapeutic potential, demonstrating efficacy for treating depression, post-traumatic stress disorder (PTSD), anxiety disorders, substance abuse disorder, and alcohol use disorder, among others”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [168]
In the citing paper
“these medicines have demonstrated efficacy across a range of neuropsychiatric disorders including depression, PTSD, and addiction (156, 168–172)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [168]
In the citing paper
“Significant increase in self-sufficiency.”
From Virtual reality and psychedelics for the treatment of psychiatric disease: A systematic literature review (2020) · doi:10.36131/cnfioritieditore20200606 · cites this paper as Krupitsky et al. (2002)
In the citing paper
“Significant reduction in craving, in components of anhedonia and state and trait anxiety.”
From Virtual reality and psychedelics for the treatment of psychiatric disease: A systematic literature review (2020) · doi:10.36131/cnfioritieditore20200606 · cites this paper as Krupitsky et al. (2002)
In the citing paper
“no significant adverse reactions were reported.”
From Virtual reality and psychedelics for the treatment of psychiatric disease: A systematic literature review (2020) · doi:10.36131/cnfioritieditore20200606 · cites this paper as Krupitsky et al. (2002)
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 1×
“ICD-10 Structured Clinical Interview for Psychiatric Disorders (SIDI) Zung Self-rating Depression Scale (ZDS) ( Zung, 1965 ) - to assess depression Spielberger Self-rating State-Trait Anxiety Scale (SAS) (Spielberger, Anton, & Bedell, 1976) - to assess state and trait anxiety Visual Analog Scale of Craving (VASC) - 10…”
MethodAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“A long lasting anti-depressant effect of a single ketamine hallucinogenic experience has also been recently noted by Berman et al. (2000). Both groups showed a significant reduction in the severity of the syndrome of anhedonia, which appears to be a protracted withdrawal syndrome, and occurred more quickly than did tr…”
Journal of Individual Psychology
Meredith, C. W., & Evans, T. D. (1989) · Cited by 2,366
Locus of control in personality
Phares, E. J. (1976) · Medical Entomology and Zoology · Cited by 1,120
Dahlstrom, W. G., Welsh, G. S., & Dahlstrom, L. E. (1972) · University of Minnesota Press eBooks · Cited by 609
Cross-validation of Purpose-in-Life test based on Frankl's concepts.
Crumbaugh, J. C. (1968) · PubMed · Cited by 548
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · cited 2×
“Acute psychological responses to the ketamine experience were evaluated with the Hallucinogen Rating Scale, an instrument developed using N,N-dimethyltryptamine (DMT), as the normative agent (Strassman et al., 1994) (Table 1).”
BackgroundMethodSelf-citationBowdle, A. T., Radant, A. D., Cowley, D. S., Kharasch, E. D., Strassman, R. J., & Roy-Byrne, P. P. (1998) · Anesthesiology · doi:10.1097/00000542-199801000-00015 · Cited by 371
Self-citationEmotions and Anxiety: New Concepts, Methods, and Applications
Zuckerman, M., & Spielberger, C. D. (1976) · Medical Entomology and Zoology · Cited by 328
Research works printed but not linked: 4
- Jansen, 1997, The ketamine model of the near-death experience: a central role for the NMDA receptor, Journal of Near-Death Studies, 16, 5, 10.1023/a:1025055109480 · doi:10.1023/a:1025055109480
- Krupitsky, 1999, The syndrome of anhedonia in recently detoxified heroin addicts: Assessment and treatment, MAPS Bulletin, 9, 40
- Leuner, 1977, Guided affective imagery: An account of its developmental history, Journal of Mental Imagery, 1, 73
- Lotsof, 1995, Ibogaine in the treatment of chemical dependency disorders: clinical perspectives, MAPS Bulletin, 5, 16
Cited by
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
“Additionally, it has shown promise for treating PTSD (Feder et al., 2014) and heroin addiction (Krupitsky et al., 2002).”
BackgroundThe neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
“Follow-up studies in the first 2 years revealed a higher rate of abstinence, greater and longer-lasting reductions in craving, and a positive change in nonverbal, unconscious emotional attitude in subjects who had been treated with a high dose, compared with a low dose, of ketamin”
Resultdos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306
Majić, T., Schmidt, T. T., & Gallinat, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568040 · Cited by 261
“A standardized procedure for a single session, or repeated sessions, uses ketamine at a sub-anesthetic (= psychotomimetic) dose embedded within up to 15 sessions of drug-free, ‘existentially oriented’ psychotherapy as preparation and follow-up (Krupitsky and Grinenko, 1997; Krupitsky et al., 2002).”
BackgroundMethodInfluentialKetamine abuse potential and use disorder
Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.016 · Cited by 256
Metadata
- Authors
- Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A.
- ORCID
- Krupitsky, Evgeny
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 23
- Issue
- 4
- Pages
- 273-283
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W2154766235
- Cited by
- 246
- References
- 33
- Citations by year
- 2026: 17 · 2025: 39 · 2024: 24 · 2023: 19 · 2022: 20 · 2021: 20 · 2020: 14 · 2019: 8 · 2018: 13 · 2017: 3 · 2016: 13 · 2015: 12 · 2014: 6 · 2013: 5 · 2012: 3
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Substance Abuse Treatment (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heffter Research Institute
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- heroin addiction, guided imagery, abstinence, heroin craving, opioid dependence treatment
- MeSH terms
- Adolescent, Adult, Anesthetics, Dissociative, Anxiety, Attitude, Depression, Double-Blind Method, Female, Follow-Up Studies, Hallucinogens, Heroin Dependence, Humans, Internal-External Control, Ketamine, Life Change Events, Male, MMPI, Psychotherapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. https://app.cochat.ai/papers/10.1016/s0740-5472(02)00275-1
- The paper
- Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A. (2002). Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. Journal of Substance Abuse Treatment. https://doi.org/10.1016/s0740-5472(02)00275-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.